1. Home
  2. HBNC vs NNNN Comparison

HBNC vs NNNN Comparison

Compare HBNC & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Horizon Bancorp Inc.

HBNC

Horizon Bancorp Inc.

HOLD

Current Price

$17.29

Market Cap

883.5M

Sector

Finance

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$37.00

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBNC
NNNN
Founded
1873
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
883.5M
1.0B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
HBNC
NNNN
Price
$17.29
$37.00
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$19.67
N/A
AVG Volume (30 Days)
236.6K
25.5K
Earning Date
01-21-2026
04-28-2026
Dividend Yield
3.69%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.06
Revenue
N/A
$8,185,146.00
Revenue This Year
$51.78
N/A
Revenue Next Year
$7.40
N/A
P/E Ratio
N/A
$804.26
Revenue Growth
1.91
21.95
52 Week Low
$12.70
$5.18
52 Week High
$18.54
$55.65

Technical Indicators

Market Signals
Indicator
HBNC
NNNN
Relative Strength Index (RSI) 65.96 67.42
Support Level $16.95 $21.13
Resistance Level $17.61 $29.38
Average True Range (ATR) 0.37 4.90
MACD 0.11 2.01
Stochastic Oscillator 85.08 75.29

Price Performance

Historical Comparison
HBNC
NNNN

About HBNC Horizon Bancorp Inc.

Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: